Repro Med Systems Inc (REPR)

[blue_skies]

Company not very forthcoming on guidance, other indications etc. Not unusual for such a small company.
I see the company as doing a good job of honestly managing investor expectations given the time window. They told stockholders to expect to see continued high legal expenses.

I would have liked a more in depth answer on the Grifols/Xemblify question.
My understanding is that sales to Grifols will start in the fourth quarter and will accelerate through 2020. A better sense of the projected numbers will come into focus later this year. Maybe something will be said in the next CC.

I was hopeful the legal fees would be minimized for rest of year. Company indicated otherwise.I’m wondering if a reasonable settlement (if possible) would be best way to go. I have zero knowledge of the complexities of the case etc. Me too. I see RMS as taking a very controlled measured approach. The company received a favorable judgement in Texas. RMS is playing from a strong hand and they know it! .

Plan on holding this long term as the story is solid. My largest position (MJCO, BMRA) Agreed. Strong growth, no debt, in expanding markets, good management team up-listing expected soon. I see this as a growth stock with minimal risk

Encouraged by bounce, so far, directly off the 10 week moving average.
Not unreasonable for this to consolidate for some time after huge % move. Agreed nice bounce indicating investors are looking past the short term legal expenses.

Of course I’d prefer a quick move to $4.50 :$ Think double digits